Tai Yin Yang
Director/Board Member at KODIAK SCIENCES INC.
Net worth: 11 106 $ as of 2024-04-29
Profile
Tai Yin Yang is currently an Independent Director at Kodiak Sciences, Inc., Kronos Bio, Inc., and Brii Biosciences Ltd.
(China).
They are also a Member of the American Chemical Society, the National Academy of Engineering, the American Association of Pharmaceutical Scientists, and the Drug Information Association.
Additionally, they serve as a Scientific Advisor at Sionna Therapeutics, Inc. In the past, Dr. Yang worked as a Director-Analytical Chemistry at Syntex Corp.
They also held the position of EVP-Pharmaceutical Development & Manufacturing at Gilead Sciences, Inc. from 2015 to 2022.
Dr. Yang holds a doctorate degree from the University of Southern California and an undergraduate degree from National Taiwan University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
KRONOS BIO INC
0.02% | 2024-03-30 | 11,333 ( 0.02% ) | 11 106 $ | 2024-04-29 |
KODIAK SCIENCES, INC.
-.--% | 2024-03-31 | 0 ( -.--% ) | - $ | 2024-04-29 |
Tai Yin Yang active positions
Companies | Position | Start |
---|---|---|
KODIAK SCIENCES INC. | Director/Board Member | 2019-12-16 |
KRONOS BIO, INC. | Director/Board Member | 2021-03-24 |
BRII BIOSCIENCES LIMITED | Director/Board Member | 2022-08-31 |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Corporate Officer/Principal | - |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Corporate Officer/Principal | - |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Corporate Officer/Principal | 2021-12-31 |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Corporate Officer/Principal | - |
Former positions of Tai Yin Yang
Companies | Position | End |
---|---|---|
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2022-07-17 |
░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Tai Yin Yang
National Taiwan University | Undergraduate Degree |
University of Southern California | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
KODIAK SCIENCES INC. | Health Technology |
KRONOS BIO, INC. | Health Technology |
BRII BIOSCIENCES LIMITED | Commercial Services |
Private companies | 6 |
---|---|
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
Syntex Corp. | Health Technology |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Commercial Services |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Health Services |
- Stock Market
- Insiders
- Tai Yin Yang